Since both insulin resistance and obesity genotypes were demonstrated associated with colorectal cancer risk, it was reasonable to believe the interactions between variants of ADIPOQ and its receptor genes played a role in carcinogenesis of colorectal cancer [39]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.